Bright Horizons Family Solutions Inc.
BFAM News Today: Stay Updated with the Latest Bright Horizons Family Solutions Inc. News in Real Time
Find BFAM news now at Meyka AI. Stay informed with the latest Bright Horizons Family Solutions Inc. stocks updates, including price news, market analysis, and expert insights.
0638.HK Fibocom Wireless Earnings: Q1 2026 Results
Fibocom Wireless (0638.HK) reported Q1 2026 earnings with $1.93B revenue and $0.0124 EPS on April 23, 2026.
DMN Stock Plunges 86% in One Year as Damon Inc. Faces Challenges
DMN stock trades at $0.0017 with 2.2B volume. Damon Inc. faces steep 86% decline over 12 months amid operational headwinds.
MTRAF: BMO Capital Maintains Outperform Rating April 2026
BMO Capital maintains Outperform rating on Metro Inc. (MTRAF) with price target lowered to C$105 from C$110 on April 23, 2026.
3NIO.AS Stock Plunges 16.36% on EURONEXT, April 24 2026
3NIO.AS stock crashes 16.36% to €20.98 on EURONEXT. Leverage Shares 3x Long NIO ETC faces sharp decline amid market volatility.
DeepSeek Makes a Comeback with a New Model Following Viral Success
DeepSeek is back in the spotlight as it launches a new artificial intelligence model after its earlier viral success shocked the global tech market. The Chinese AI startup had gained rapid attention for delivering strong performance at lower cost, raising questions about global AI competition and pricing models. Now, with its latest release, DeepSeek is…
Supreme Court Adoption Ruling April 24: Final and Permanent
Supreme Court rules adoption orders are final and permanent in UK law. Landmark ruling clarifies implications for adoptive families and child welfare.
TMXXF Maintains Outperform at RBC Capital, April 2026
RBC Capital maintains Outperform rating on TMXXF, raising price target to C$65 from C$64 on April 23, 2026.
Joan Phillip MLA April 24: B.C. Premier Calls for Prayers
Premier David Eby says NDP MLA Joan Phillip is hospitalized and “very ill” facing undisclosed health challenges.
1513.HK Livzon Pharmaceutical Misses Q1 2026 Earnings Targets
Livzon Pharmaceutical (1513.HK) missed EPS and revenue estimates in April. EPS down 9.66%, revenue down 9.50%. Stock at HK$28.26.